Leading Tac
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $14M
Investors
- 8
About Leading Tac
, trading as Leading Tac, operates as a biopharmaceutical company that focuses on the development of an innovative small molecule drug. In 2023, the company acquired approval from China's NMPA. The company's main business is the research and development of innovative small molecule drugs. It established two biopharmaceutical platforms, which are Nano-SPUD and Lyso-SPUD. Nano-SPUD is a targeted protein ubiquitination and degradation platform for the screening and development of intracellular proteins and E3 ligases. Its IRAK4 degrader can be used to treat atopic dermatitis, rare autoimmune diseases, AML, MDS and other blood tumor diseases. The company generates revenue by providing innovative small molecule drugs.
Who invested in Leading Tac
8 investors across 3 rounds
See all investors in Leading Tac
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leading Tac
Who invested in Leading Tac?
Leading Tac has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leading Tac raised?
Leading Tac has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Leading Tac last raise money?
Leading Tac's most recent round on record is a Series B, in Dec 2025.
What does Leading Tac do?
, trading as Leading Tac, operates as a biopharmaceutical company that focuses on the development of an innovative small molecule drug.
Where is Leading Tac headquartered?
Leading Tac is headquartered in Shanghai, China.
Which VCs invest in companies like Leading Tac?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Leading Tac's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Leading Tac? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.